277 related articles for article (PubMed ID: 37972355)
1. The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer's Like Brain Changes on Severely SARS-CoV-2 Infected Patients.
Rahman MR; Akter R; Neelotpol S; Mayesha II; Afrose A
Am J Alzheimers Dis Other Demen; 2023; 38():15333175231214974. PubMed ID: 37972355
[TBL] [Abstract][Full Text] [Related]
2. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.
Zhou Y; Xu J; Hou Y; Leverenz JB; Kallianpur A; Mehra R; Liu Y; Yu H; Pieper AA; Jehi L; Cheng F
Alzheimers Res Ther; 2021 Jun; 13(1):110. PubMed ID: 34108016
[TBL] [Abstract][Full Text] [Related]
3. Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa.
Shahbaz MA; Kuivanen S; Lampinen R; Mussalo L; Hron T; Závodná T; Ojha R; Krejčík Z; Saveleva L; Tahir NA; Kalapudas J; Koivisto AM; Penttilä E; Löppönen H; Singh P; Topinka J; Vapalahti O; Chew S; Balistreri G; Kanninen KM
J Neuroinflammation; 2023 Dec; 20(1):299. PubMed ID: 38098019
[TBL] [Abstract][Full Text] [Related]
4. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
5. Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?
Rudnicka-Drożak E; Drożak P; Mizerski G; Zaborowski T; Ślusarska B; Nowicki G; Drożak M
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767513
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
Chiricosta L; Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer's Disease.
Kosenko E; Tikhonova L; Alilova G; Montoliu C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982809
[TBL] [Abstract][Full Text] [Related]
9. Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis.
Fan Y; Liu X; Guan F; Hang X; He X; Jin J
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257800
[TBL] [Abstract][Full Text] [Related]
10. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
Chen F; Chen Y; Wang Y; Ke Q; Cui L
Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
[TBL] [Abstract][Full Text] [Related]
11. Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects.
Griggs E; Trageser K; Naughton S; Yang EJ; Mathew B; Van Hyfte G; Hellmers L; Jette N; Estill M; Shen L; Fischer T; Pasinetti GM
Elife; 2023 Jul; 12():. PubMed ID: 37417740
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's-like signaling in brains of COVID-19 patients.
Reiken S; Sittenfeld L; Dridi H; Liu Y; Liu X; Marks AR
Alzheimers Dement; 2022 May; 18(5):955-965. PubMed ID: 35112786
[TBL] [Abstract][Full Text] [Related]
13. The interference between SARS-COV-2 and Alzheimer's disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic.
Mansour HM
Ageing Res Rev; 2024 Feb; 94():102195. PubMed ID: 38244862
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and Alzheimer's Disease: A Literature Review.
Hardan L; Filtchev D; Kassem R; Bourgi R; Lukomska-Szymanska M; Tarhini H; Salloum-Yared F; Mancino D; Kharouf N; Haikel Y
Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833377
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.
Bartolomé F; Rosa L; Valenti P; Lopera F; Hernández-Gallego J; Cantero JL; Orive G; Carro E
Front Immunol; 2022; 13():878201. PubMed ID: 35547737
[TBL] [Abstract][Full Text] [Related]
17. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Alzheimer's Disease: What Is the Connection?
Itzhaki RF
J Alzheimers Dis; 2023; 91(4):1273-1276. PubMed ID: 36591656
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 as a Risk Factor for Alzheimer's Disease.
Golzari-Sorkheh M; Weaver DF; Reed MA
J Alzheimers Dis; 2023; 91(1):1-23. PubMed ID: 36314211
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer's disease.
Chen J; Chen J; Lei Z; Zhang F; Zeng LH; Wu X; Li S; Tan J
Transl Psychiatry; 2023 Dec; 13(1):396. PubMed ID: 38104129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
